Establish a strong foundation for commercially successful therapies and advance from concept to candidate with Element's integrated discovery biology services.
Accelerate pre-clinical drug discovery with Element’s extensive offering of biochemical and cell-based assays. Our discovery biology services are built upon a foundation of deep expertise in biochemistry, signal transduction, and cell biology. Interested in discovery biology services? Request more information.
Extensive biochemical assays
Leverage our portfolio of biochemical assays that includes >600 druggable protein targets, including kinases, proteases, phosphatases - and many other enzymes regulating cell survival and apoptosis, epigenetic and metabolic circuits, and protein homeostasis. Flexible assay formats range from HTS and high content profiling to sophisticated mechanism of action (MOA) studies.
In addition to extensive experience performing high throughput screening for broad kinase, epigenetic and protein homeostasis, new new biochemical and cell-based assays can be developed quickly using modern detection methods, including TR-FRET, FP, BRET, Flow-Cytometry, LC-MS/MS, and state-of-the-art compound delivery approaches (acoustic dispensing). New assays are tailored to meet your needs and fully validated with highly standardized procedures. Looking to talk about your discovery biology and biochemical assay needs? Get in touch with us today.
Comprehensive cell-based assays and bioassays
Our cell-based assays utilize a large in-house collection of stable cell lines as well as primary cells and whole human blood. We perform intracellular drug-target engagement assays, phosphoprotein accumulation, and protein degradation assays. Plus, we offer cytokine ELISA, cell proliferation, and multiplex flow cytometry assays. Want to know more? Start the conversation.
The Element advantage
We're committed to helping you accelerate pre-clinical discovery with our systematic approach, aligning biochemical profiling and cell-based screening activities. So, let's talk about your goals and how we can make a difference.
Explore the complete list of discovery biology assays we offer
Still researching? Click the orange "view assays" button for the full list of available discovery biology assays.
wt Kinase Assays
Click the orange "view assays" button to see the full list of available wt kinase assays.
NanoBRET Kinase Assays
Click the orange "view assays" button to see the full list of available NanoBRET assays.
Mutant Kinase Assays
Click the orange "view assays" button to see the full list of available mutant kinase assays.
Biochemical Binding Assays
Click the orange "view assays" button to see the full list of available biochemical binding assays.
PDE Assays
Click the orange "view assays" button to see the full list of available PDE assays.
Phosphatase Assays
Click the orange "view assays" button to see the full list of available phosphatase assays.
Epigenetic Assays
Click the orange "view assays" button to see the full list of available epigenetic assays.
Protease Assays
Click the orange "view assays" button to see the full list of available protease assays.
Learn more
CMC Product Development Services
Our CMC product development services include formulation development, parenteral and topical product development, microbiology testing services, and consultancy.
Pre-Clinical and GMP Clinical Trial Material Manufacturing
Element offers flexible, complete and seamless clinical-scale manufacturing support throughout the entire drug development life cycle, from pre-clinical manufacturing services to phase I and II clinical trial material manufacturing solutions.
Pharmaceutical Pre-Formulation & Formulation Development Services
Element’s pre-formulation and formulation development services help enhance delivery performance and stability of your parenteral, ophthalmic, and topical drug products.
Chemistry, Manufacturing, and Controls (CMC) Consulting Services
We provide consulting services for Chemistry, Manufacturing, and Controls (CMC) product development in the pharmaceutical and biotechnological industries.